Maternal and infant gene-folate interactions and the risk of neural tube defects

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 10, 2012, Pages 2439-2446

  Etheredge, Analee J ^a   Finnell, Richard H ^b   Carmichael, Suzan L ^c   Lammer, Edward J ^d   Zhu, Huiping ^b   Mitchell, Laura E ^b   Shaw, Gary M ^c  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Congenital abnormalities; Folic acid; Genetic association studies; Maternal nutritional physiological phenomena; Molecular epidemiology; Nervous system malformations; Neural tube defects; Nutrigenomics

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FETUS; FOOD FREQUENCY QUESTIONNAIRE; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; MTHFD1 GENE; MTHFR GENE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK FACTOR; SHMT1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TYMS GENE; UNITED STATES; VITAMIN INTAKE;

ADULT; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP); NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RISK FACTORS; YOUNG ADULT;

EID: 84866491881     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35552     Document Type: Article

References (37)

1. Beaudin AE, Stover PJ. 2009. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: A minireview. Birth Defects Res Part A Clin Mol Teratol 85: 274-284.
2. Bell KN, Oakley GP Jr. 2009. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 85: 102-107.
3. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. 1986. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124: 453-469.
4. Block G, Woods M, Potosky A, Clifford C. 1990. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43: 1327-1335.
5. Botto LD, Lisi A, Bower C, Canfield MA, Dattani N, De Vigan C, De Walle H, Erickson DJ, Halliday J, Irgens LM, et al. 2006. Trends of selected malformations in relation to folic acid recommendations and fortification: An international assessment. Birth Defects Res A Clin Mol Teratol 76: 693-705.
6. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL, Molloy AM, O'Leary VB, Parle-McDermott A, Scott JM, et al. 2002. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet 71: 1207-1215.
7. Carmichael SL, Yang W, Shaw GM. 2010. Periconceptional nutrient intakes and risks of neural tube defects in California. Birth Defects Res A Clin Mol Teratol 88: 670-678.
8. Carroll N, Pangilinan F, Molloy AM, Troendle J, Mills JL, Kirke PN, Brody LC, Scott JM, Parle-McDermott A. 2009. Analysis of the MTHFD1 promoter and risk of neural tube defects. Hum Genet 125: 247-256.
9. Christensen KE, Rohlicek CV, Andelfinger GU, Michaud J, Bigras JL, Richter A, Mackenzie RE, Rozen R. 2009. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum Mutat 30: 212-220.
10. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 1832-1835.
11. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, Capra V. 2006. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J Hum Genet 51: 98-103.
12. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. 2005. Human neural tube defects: Developmental biology, epidemiology, and genetics. Neurotoxicol Teratol 27: 515-524.
13. Doudney K, Grinham J, Whittaker J, Lynch SA, Thompson D, Moore GE, Copp AJ, Greene ND, Stanier P. 2009. Evaluation of folate metabolism gene polymorphisms as risk factors for open and closed neural tube defects. Am J Med Genet Part A 149A: 1585-1589.
14. Franke B, Vermeulen S, Steegers-Theunissen RPM, Coenen MJ, Schijvenaars M, Scheffer H, den Heijer M, Blom HJ. 2009. An association study of 45 folate-related genes in spina bifida: involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res Part A Clin Mol Teratol 85: 216-226.
15. Greene ND, Stanier P, Copp AJ. 2009. Genetics of human neural tube defects. Hum Mol Genet 18: R113-R129.
16. Heil SG, Van der Put NM, Waas ET, den Heijer M, Trijbels FJ, Blom HJ. 2001. Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects? Mol Genet Metab 73: 164-172.
17. Konrad C, Muller GA, Langer C, Kuhlenbaumer G, Berger K, Nabavi DG, Dziewas R, Stogbauer F, Ringelstein EB, Junker R. 2004. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol 251: 1242-1248.
18. Martinez CA, Northrup H, Lin JI, Morrison AC, Fletcher JM, Tyerman GH, Au KS. 2009. Genetic association study of putative functional single nucleotide polymorphisms of genes in folate metabolism and spina bifida. Am J Obstet Gynecol 201: 394.e1-394.e11.
19. Mitchell LE. 1997. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium. Am J Hum Genet 60: 1006-1007.
20. MRC. 1991. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 338: 131-137.
21. Parle-McDermott A, Kirke PN, Mills JL, Molloy AM, Cox C, O'Leary VB, Pangilinan F, Conley M, Cleary L, Brody LC, et al. 2006. Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur J Hum Genet 14: 768-772.
22. Relton CL, Wilding CS, Laffling AJ, Jonas PA, Burgess T, Binks K, Tawn EJ, Burn J. 2004. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 81: 273-281.
23. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW. 1993. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet 2: 159-163.
24. Schulman J, Hahn JA. 1993. Quality-control of birth defect registry data-A case study. Public Health Rep 108: 91-98.
25. Shaw GM, Lammer EJ, Zhu H, Baker MW, Neri E, Finnell RH. 2002. Maternal periconceptional vitamin use, genetic variation of infant reduced folate carrier (A80G), and risk of spina bifida. Am J Med Genet 108: 1-6.
26. Shaw GM, Lu W, Zhu HP, Yang W, Briggs FBS, Carmichael SL, Barcellos LF, Lammer EJ, Finnell RH. 2009. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 10: 11.
27. Shaw GM, Rozen R, Finnell RH, Wasserman CR, Lammer EJ. 1998. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 148: 30-37.
28. Trinh BN, Ong CN, Coetzee GA, Yu MC, Laird PW. 2002. Thymidylate synthase: A novel genetic determinant of plasma homocysteine and folate levels. Hum Genet 111: 299-302.
29. Ulrich CM, Bigler J, Bostick R, Fosdick L, Potter JD. 2002. Thymidylate synthase promoter polymorphism, interaction with folate intake, and risk of colorectal adenomas. Cancer Res 62: 3361-3364.
30. van der Linden IJ, Heil SG, Kouwenberg IC, den Heijer M, Blom HJ. 2007. The methylenetetrahydrofolate dehydrogenase (MTHFD1) 1958G>A variant is not associated with spina bifida risk in the Dutch population. Clin Genet 72: 599-600.
31. Volcik KA, Shaw GM, Lammer EJ, Zhu H, Finnell RH. 2003a. Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res Part A Clin Mol Teratol 67: 154-157.
32. Volcik KA, Shaw GM, Zhu H, Lammer EJ, Laurent C, Finnell RH. 2003b. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res A Clin Mol Teratol 67: 924-928.
33. Vollset SE, Botto LD. 2005. Neural tube defects, other congenital malformations and single nucleotide polymorphisms in the 5, 10 methylenetetrahydrofolate reductase (MTHFR) gene. MTHFR polymorphisms and disease. Georgetown, TX: Landes Bioscience, Eurekah.com. p 210.
34. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62: 969-978.
35. Wilcox AJ, Weinberg CR, Lie RT. 1998. Distinguishing the effects of maternal and offspring genes through studies of "case-parent triads." Am J Epidemiol 148: 893-901.
36. Wilding CS, Relton CL, Sutton MJ, Jonas PA, Lynch SA, Tawn EJ, Burn J. 2004. Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom. Birth Defects Res Part A Clin Mol Teratol 70: 483-485.
37. Woeller CF, Anderson DD, Szebenyi DM, Stover PJ. 2007. Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway. J Biol Chem 282: 17623-17631.